View in EDS

NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways.

Saved in:
Bibliographic Details
Title: NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways.
Authors: Kageyama K; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan. Electronic address: ki.kageyama@po.nippon-shinyaku.co.jp., Kikuchi E; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan., Hoshino N; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan., Ito M; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan., Akiyama S; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan., Shiba Y; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan.
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2026 Feb; Vol. 393 (2), pp. 103806. Date of Electronic Publication: 2026 Jan 07.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41633022
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kageyama+K%22">Kageyama K</searchLink>; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan. Electronic address: ki.kageyama@po.nippon-shinyaku.co.jp.<br /><searchLink fieldCode="AU" term="%22Kikuchi+E%22">Kikuchi E</searchLink>; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Hoshino+N%22">Hoshino N</searchLink>; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Ito+M%22">Ito M</searchLink>; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Akiyama+S%22">Akiyama S</searchLink>; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Shiba+Y%22">Shiba Y</searchLink>; Discovery Research Laboratories, Nippon Shinyaku Co, Ltd, Kyoto, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 2026 Feb; Vol. 393 (2), pp. 103806. <i>Date of Electronic Publication: </i>2026 Jan 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Pharmacology+and+Experimental+Therapeutics%22">American Society for Pharmacology and Experimental Therapeutics </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-0103 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41633022
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jpet.2026.103806
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 103806
    Titles:
      – TitleFull: NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kageyama K
      – PersonEntity:
          Name:
            NameFull: Kikuchi E
      – PersonEntity:
          Name:
            NameFull: Hoshino N
      – PersonEntity:
          Name:
            NameFull: Ito M
      – PersonEntity:
          Name:
            NameFull: Akiyama S
      – PersonEntity:
          Name:
            NameFull: Shiba Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1521-0103
          Numbering:
            – Type: volume
              Value: 393
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The Journal of pharmacology and experimental therapeutics
              Type: main
ResultId 1